Levoketoconazole

左酮康唑

Report date: 2025/12/05 16:14:37

Base Information

Drug NameLevoketoconazole
Drug Alias NamelevoketoconazolumlevoketoconazolLevdexketoconazoleRecorlevNormoCort +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 11-beta-hydroxylase inhibitorsCytochrome P450 11A1 inhibitorsSteroid 17-alpha-hydroxylase inhibitors
TargetsSteroid 11-beta-hydroxylaseCytochrome P450 11A1Steroid 17-alpha-hydroxylase
Therapy Area/IndicationsCushing SyndromeDiabetes Mellitus, Type 2
Global Approved IndicationsCushing Syndrome
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/12/30
Country/TerritoryCzechiaBelgiumBulgaria +[20] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesStrategia Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesCortendo AbStrongbridge Dublin Ltd
Inactive CompaniesDiobex Inc
Active IndicationsCushing Syndrome
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A